✦ LIBER ✦

OPEN LABEL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF YOKUKANSAN, A TRADITIONAL ASIAN MEDICINE, IN DEMENTIA WITH LEWY BODIES

✍ Scribed by Koh Iwasaki; Kenji Kosaka; Hideo Mori; Reina Okitsu; Katsutoshi Furukawa; Yuta Manabe; Mitsuhiro Yoshita; Aya Kanamori; Nobuo Ito; Kenji Wada; Michio Kitayama; Jun Horiguchi; Shuhei Yamaguchi; Ryuji Fukuhara; Shinji Ouma; Seigo Nakano; Mamoru Hashimoto; Toru Kinoshita

Book ID: 109132662
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 65 KB
Volume: 59
Category: Article
ISSN: 0002-8614
DOI: 10.1111/j.1532-5415.2011.03373.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter, open-label, dose-ranging

A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis

✍ Kiwamu Okita; Isao Sakaida; Mitsuru Okada; Akira Kaneko; Kazuaki Chayama; Michio 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 329 KB

Erratum to: A multicenter, open-label, d

Erratum to: A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis

✍ Kiwamu Okita; Isao Sakaida; Mitsuru Okada; Akira Kaneko; Kazuaki Chayama; Michio 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 75 KB

Open-Label Randomized Trial of the Safet

Open-Label Randomized Trial of the Safety and Efficacy of a Single Dose Conivaptan to Raise Serum Sodium in Patients with Traumatic Brain Injury

✍ Christopher Galton; Steven Deem; N. David Yanez; Michael Souter; Randall Chesnut 📂 Article 📅 2011 🏛 Humana Press Inc 🌐 English ⚖ 306 KB

A Multicenter, Prospective, Open Label,

A Multicenter, Prospective, Open Label, Historically Controlled Clinical Trial to Evaluate Efficacy and Safety in Primary Immunodeficiency Diseases (PID) Patients of Flebogamma®5% DIF, the Next Generation of Flebogamma®

✍ Melvin Berger; The Flebogamma® 5% DIF Investigators 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 126 KB

AFFECT: a prospective, open-label, multi

AFFECT: a prospective, open-label, multicenter trial to evaluate the feasibility and safety of a short-term treatment with subcutaneous certoparin in patients with persistent non-valvular atrial fibrillation

✍ Ulrich Tebbe; Ralph Oeckinghaus; Karl-Friedrich Appel; Hubertus Heuer; Hendrik H 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 267 KB

An open, multi-centre, phase II clinical

An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer

✍ Chao, Y; Li, C P; Chao, T Y; Su, W C; Hsieh, R K; Wu, M F; Yeh, K H; Kao, W Y; C 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 109 KB